Let’s talk about what you want to know about serous ovarian cysts!

Serous ovarian cyst is one of the common gynecological diseases in life. This disease has a great impact on women's health, so patients must be treated as early as possible to avoid worsening of the disease. Let us take a detailed look at serous ovarian cysts.

What is a serous ovarian cyst?

Serous cystadenoma is the most common type of ovarian epithelial tumor, with an incidence of 25% of all ovarian tumors. Serous cystadenoma accounts for more than half of ovarian malignant tumors. The tumor epithelium is mainly composed of epithelium similar to the fallopian tube mucosa. At present, the cause of ovarian tumors is not very clear, and its occurrence may be related to environmental, endocrine and genetic factors. Ovarian serous tumors can be divided into three types: cystadenoma, borderline, and cystadenocarcinoma.

Clinical manifestations of serous ovarian cysts

1. Serous cystadenoma: The most common age is 30-40 years old. Common abdominal masses are mostly bilateral. In the early stage, when the mass is small, there may be no obvious symptoms. When the mass increases or there is ascites, there will be a feeling of abdominal distension. The exophytic papillae of serous surface papilloma can often fall off and implant on the surface of peritoneum and pelvic organs, so ascites symptoms are more common.

2. Borderline tumor: It is common in women aged 31-40 years old. The symptoms are the same as those of serous cystadenoma. Examination may reveal a spherical mass that can be felt on one or both sides of the uterus. Abdominal examination may reveal mobile dullness.

3. Serous papillary cystadenocarcinoma: It is common in people aged 40-60 years. The tumor grows slowly and often forms a large mass, compressing adjacent organs and causing compression symptoms, or accompanied by ascites. The nipple tissue is brittle and easy to fall off, and has a tendency to invade the tumor capsule. When the nipple occurs on the surface of the tumor, intra-abdominal dissemination may occur and may be implanted in the peritoneum, greater omentum, internal reproductive organs, intestinal serosa, and other pelvic organs.